D P Healy

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi request reprint Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate
    D P Healy
    College of Pharmacy, University of Cincinnati, OH 45267, USA
    Ann Pharmacother 31:1460-4. 1997
  2. ncbi request reprint Macrolide immunomodulation of chronic respiratory diseases
    Daniel P Healy
    College of Pharmacy, University of Cincinnati Medical Center and Shriners Hospitals for Children, 3225 Eden Avenue, P O Box 670004, Cincinnati, OH 45267 0004, USA
    Curr Infect Dis Rep 9:7-13. 2007
  3. ncbi request reprint New and emerging therapies for sepsis
    Daniel P Healy
    College of Pharmacy, University of Cincinnati, and Shriners Hospitals for Children, PO Box 670004, Cincinnati, OH 45267 0004, USA
    Ann Pharmacother 36:648-54. 2002
  4. pmc Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes
    D P Healy
    College of Pharmacy, University of Cincinnati, Ohio 45267, USA
    Antimicrob Agents Chemother 40:6-10. 1996

Detail Information

Publications4

  1. ncbi request reprint Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate
    D P Healy
    College of Pharmacy, University of Cincinnati, OH 45267, USA
    Ann Pharmacother 31:1460-4. 1997
    ..As a result, there is renewed interest in the interaction between tetracycline and bismuth subsalicylate...
  2. ncbi request reprint Macrolide immunomodulation of chronic respiratory diseases
    Daniel P Healy
    College of Pharmacy, University of Cincinnati Medical Center and Shriners Hospitals for Children, 3225 Eden Avenue, P O Box 670004, Cincinnati, OH 45267 0004, USA
    Curr Infect Dis Rep 9:7-13. 2007
    ..Preliminary data (largely from open-label trials) are promising, but conclusive results are needed...
  3. ncbi request reprint New and emerging therapies for sepsis
    Daniel P Healy
    College of Pharmacy, University of Cincinnati, and Shriners Hospitals for Children, PO Box 670004, Cincinnati, OH 45267 0004, USA
    Ann Pharmacother 36:648-54. 2002
    ..To review the recent advances related to the pathophysiology of sepsis and the rationale for recombinant human-activated protein C (drotrecogin alfa) and other antisepsis agents currently in Phase III trials...
  4. pmc Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes
    D P Healy
    College of Pharmacy, University of Cincinnati, Ohio 45267, USA
    Antimicrob Agents Chemother 40:6-10. 1996
    ....